nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—SRMS—gall bladder—duodenum cancer	0.0188	0.0191	CbGeAlD
Bosutinib—STK26—gall bladder—duodenum cancer	0.0178	0.018	CbGeAlD
Bosutinib—WEE2—endocrine gland—duodenum cancer	0.0128	0.013	CbGeAlD
Bosutinib—CLK3—pancreas—duodenum cancer	0.00908	0.00919	CbGeAlD
Bosutinib—VRK2—pancreas—duodenum cancer	0.00851	0.00862	CbGeAlD
Bosutinib—STK26—pancreas—duodenum cancer	0.00819	0.00829	CbGeAlD
Bosutinib—STK33—digestive system—duodenum cancer	0.00815	0.00826	CbGeAlD
Bosutinib—WEE1—pancreas—duodenum cancer	0.00784	0.00794	CbGeAlD
Bosutinib—CLK3—digestive system—duodenum cancer	0.00775	0.00785	CbGeAlD
Bosutinib—EPHB2—digestive system—duodenum cancer	0.00758	0.00767	CbGeAlD
Bosutinib—STK25—pancreas—duodenum cancer	0.00749	0.00758	CbGeAlD
Bosutinib—SRMS—digestive system—duodenum cancer	0.00742	0.00751	CbGeAlD
Bosutinib—PLK2—pancreas—duodenum cancer	0.00728	0.00737	CbGeAlD
Bosutinib—IKBKE—lymph node—duodenum cancer	0.00723	0.00732	CbGeAlD
Bosutinib—SYK—digestive system—duodenum cancer	0.00712	0.00722	CbGeAlD
Bosutinib—CDK2—digestive system—duodenum cancer	0.00706	0.00715	CbGeAlD
Bosutinib—STK26—digestive system—duodenum cancer	0.00699	0.00708	CbGeAlD
Bosutinib—TLK1—endocrine gland—duodenum cancer	0.00692	0.00701	CbGeAlD
Bosutinib—CAMK1D—pancreas—duodenum cancer	0.00688	0.00697	CbGeAlD
Bosutinib—PRKCQ—endocrine gland—duodenum cancer	0.00683	0.00691	CbGeAlD
Bosutinib—SIK2—endocrine gland—duodenum cancer	0.00674	0.00682	CbGeAlD
Bosutinib—STK33—endocrine gland—duodenum cancer	0.00674	0.00682	CbGeAlD
Bosutinib—WEE1—digestive system—duodenum cancer	0.0067	0.00678	CbGeAlD
Bosutinib—DMPK—digestive system—duodenum cancer	0.0067	0.00678	CbGeAlD
Bosutinib—FRK—endocrine gland—duodenum cancer	0.00656	0.00665	CbGeAlD
Bosutinib—PKMYT1—endocrine gland—duodenum cancer	0.00656	0.00665	CbGeAlD
Bosutinib—BMX—endocrine gland—duodenum cancer	0.00641	0.00649	CbGeAlD
Bosutinib—CLK3—endocrine gland—duodenum cancer	0.00641	0.00649	CbGeAlD
Bosutinib—STK25—digestive system—duodenum cancer	0.0064	0.00648	CbGeAlD
Bosutinib—HIPK4—endocrine gland—duodenum cancer	0.00633	0.00641	CbGeAlD
Bosutinib—PDGFRB—gall bladder—duodenum cancer	0.00627	0.00635	CbGeAlD
Bosutinib—PHKG1—endocrine gland—duodenum cancer	0.00626	0.00634	CbGeAlD
Bosutinib—PLK2—digestive system—duodenum cancer	0.00622	0.0063	CbGeAlD
Bosutinib—TXK—endocrine gland—duodenum cancer	0.00606	0.00614	CbGeAlD
Bosutinib—STK4—digestive system—duodenum cancer	0.00595	0.00602	CbGeAlD
Bosutinib—SYK—endocrine gland—duodenum cancer	0.00589	0.00596	CbGeAlD
Bosutinib—CDK2—endocrine gland—duodenum cancer	0.00583	0.00591	CbGeAlD
Bosutinib—STK26—endocrine gland—duodenum cancer	0.00578	0.00585	CbGeAlD
Bosutinib—MAP4K4—pancreas—duodenum cancer	0.00568	0.00575	CbGeAlD
Bosutinib—NUAK2—pancreas—duodenum cancer	0.00564	0.00571	CbGeAlD
Bosutinib—EPHA5—digestive system—duodenum cancer	0.00562	0.00569	CbGeAlD
Bosutinib—ALK—digestive system—duodenum cancer	0.00562	0.00569	CbGeAlD
Bosutinib—DMPK—endocrine gland—duodenum cancer	0.00554	0.00561	CbGeAlD
Bosutinib—WEE1—endocrine gland—duodenum cancer	0.00554	0.00561	CbGeAlD
Bosutinib—STK35—pancreas—duodenum cancer	0.00548	0.00555	CbGeAlD
Bosutinib—CSK—pancreas—duodenum cancer	0.00545	0.00551	CbGeAlD
Bosutinib—CSNK1A1—pancreas—duodenum cancer	0.00541	0.00548	CbGeAlD
Bosutinib—CLK1—pancreas—duodenum cancer	0.00538	0.00544	CbGeAlD
Bosutinib—STK25—endocrine gland—duodenum cancer	0.00529	0.00535	CbGeAlD
Bosutinib—CAMK2G—pancreas—duodenum cancer	0.00528	0.00534	CbGeAlD
Bosutinib—ROCK1—digestive system—duodenum cancer	0.00518	0.00525	CbGeAlD
Bosutinib—PLK2—endocrine gland—duodenum cancer	0.00514	0.0052	CbGeAlD
Bosutinib—SIK3—endocrine gland—duodenum cancer	0.0051	0.00517	CbGeAlD
Bosutinib—BMPR2—digestive system—duodenum cancer	0.00504	0.0051	CbGeAlD
Bosutinib—CSNK1E—pancreas—duodenum cancer	0.00501	0.00508	CbGeAlD
Bosutinib—EPHB3—digestive system—duodenum cancer	0.005	0.00506	CbGeAlD
Bosutinib—SIK1—pancreas—duodenum cancer	0.00494	0.005	CbGeAlD
Bosutinib—STK4—endocrine gland—duodenum cancer	0.00491	0.00498	CbGeAlD
Bosutinib—CAMK1D—endocrine gland—duodenum cancer	0.00486	0.00492	CbGeAlD
Bosutinib—MAP4K4—digestive system—duodenum cancer	0.00485	0.00491	CbGeAlD
Bosutinib—ERBB3—pancreas—duodenum cancer	0.00484	0.0049	CbGeAlD
Bosutinib—MAP2K2—pancreas—duodenum cancer	0.00483	0.00489	CbGeAlD
Bosutinib—TLK1—lymph node—duodenum cancer	0.00479	0.00485	CbGeAlD
Bosutinib—PRKCQ—lymph node—duodenum cancer	0.00472	0.00478	CbGeAlD
Bosutinib—PTK2—pancreas—duodenum cancer	0.00469	0.00475	CbGeAlD
Bosutinib—TBK1—pancreas—duodenum cancer	0.00469	0.00475	CbGeAlD
Bosutinib—MAP2K1—digestive system—duodenum cancer	0.00468	0.00474	CbGeAlD
Bosutinib—CSK—digestive system—duodenum cancer	0.00465	0.00471	CbGeAlD
Bosutinib—EPHA5—endocrine gland—duodenum cancer	0.00464	0.0047	CbGeAlD
Bosutinib—ALK—endocrine gland—duodenum cancer	0.00464	0.0047	CbGeAlD
Bosutinib—FER—endocrine gland—duodenum cancer	0.00464	0.0047	CbGeAlD
Bosutinib—TYRO3—endocrine gland—duodenum cancer	0.00464	0.0047	CbGeAlD
Bosutinib—CSNK1A1—digestive system—duodenum cancer	0.00462	0.00468	CbGeAlD
Bosutinib—LYN—endocrine gland—duodenum cancer	0.00462	0.00468	CbGeAlD
Bosutinib—IRAK1—pancreas—duodenum cancer	0.0046	0.00466	CbGeAlD
Bosutinib—HCK—digestive system—duodenum cancer	0.00459	0.00465	CbGeAlD
Bosutinib—CLK1—digestive system—duodenum cancer	0.00459	0.00465	CbGeAlD
Bosutinib—RPS6KB1—pancreas—duodenum cancer	0.00451	0.00457	CbGeAlD
Bosutinib—CAMK2G—digestive system—duodenum cancer	0.00451	0.00456	CbGeAlD
Bosutinib—TNK2—endocrine gland—duodenum cancer	0.00446	0.00452	CbGeAlD
Bosutinib—CLK3—lymph node—duodenum cancer	0.00443	0.00449	CbGeAlD
Bosutinib—DSTYK—lymph node—duodenum cancer	0.00443	0.00449	CbGeAlD
Bosutinib—BMX—lymph node—duodenum cancer	0.00443	0.00449	CbGeAlD
Bosutinib—MAP4K2—endocrine gland—duodenum cancer	0.0044	0.00446	CbGeAlD
Bosutinib—BLK—lymph node—duodenum cancer	0.00438	0.00443	CbGeAlD
Bosutinib—PTK2B—digestive system—duodenum cancer	0.00435	0.00441	CbGeAlD
Bosutinib—ERBB4—endocrine gland—duodenum cancer	0.00434	0.0044	CbGeAlD
Bosutinib—CASK—lymph node—duodenum cancer	0.00433	0.00438	CbGeAlD
Bosutinib—PHKG1—lymph node—duodenum cancer	0.00433	0.00438	CbGeAlD
Bosutinib—SLK—pancreas—duodenum cancer	0.0043	0.00436	CbGeAlD
Bosutinib—ROCK1—endocrine gland—duodenum cancer	0.00428	0.00434	CbGeAlD
Bosutinib—CSNK1E—digestive system—duodenum cancer	0.00428	0.00434	CbGeAlD
Bosutinib—EIF2AK1—lymph node—duodenum cancer	0.00428	0.00434	CbGeAlD
Bosutinib—EPHB4—pancreas—duodenum cancer	0.00427	0.00433	CbGeAlD
Bosutinib—TXK—lymph node—duodenum cancer	0.00419	0.00425	CbGeAlD
Bosutinib—EPHA2—pancreas—duodenum cancer	0.00419	0.00424	CbGeAlD
Bosutinib—BMPR2—endocrine gland—duodenum cancer	0.00416	0.00421	CbGeAlD
Bosutinib—VRK2—lymph node—duodenum cancer	0.00415	0.0042	CbGeAlD
Bosutinib—FES—lymph node—duodenum cancer	0.00415	0.0042	CbGeAlD
Bosutinib—ERBB3—digestive system—duodenum cancer	0.00413	0.00418	CbGeAlD
Bosutinib—STK36—endocrine gland—duodenum cancer	0.00413	0.00418	CbGeAlD
Bosutinib—ULK3—digestive system—duodenum cancer	0.00412	0.00417	CbGeAlD
Bosutinib—MAP2K2—digestive system—duodenum cancer	0.00412	0.00417	CbGeAlD
Bosutinib—MAP4K5—pancreas—duodenum cancer	0.00409	0.00414	CbGeAlD
Bosutinib—MERTK—endocrine gland—duodenum cancer	0.00408	0.00413	CbGeAlD
Bosutinib—SYK—lymph node—duodenum cancer	0.00407	0.00412	CbGeAlD
Bosutinib—TNIK—lymph node—duodenum cancer	0.00407	0.00412	CbGeAlD
Bosutinib—CDK2—lymph node—duodenum cancer	0.00403	0.00408	CbGeAlD
Bosutinib—TBK1—digestive system—duodenum cancer	0.00401	0.00406	CbGeAlD
Bosutinib—PTK2—digestive system—duodenum cancer	0.00401	0.00406	CbGeAlD
Bosutinib—MAP4K4—endocrine gland—duodenum cancer	0.00401	0.00406	CbGeAlD
Bosutinib—STK26—lymph node—duodenum cancer	0.00399	0.00405	CbGeAlD
Bosutinib—BCR—endocrine gland—duodenum cancer	0.00398	0.00403	CbGeAlD
Bosutinib—MAP3K12—endocrine gland—duodenum cancer	0.00395	0.004	CbGeAlD
Bosutinib—STK35—endocrine gland—duodenum cancer	0.00387	0.00392	CbGeAlD
Bosutinib—MAP2K1—endocrine gland—duodenum cancer	0.00387	0.00392	CbGeAlD
Bosutinib—CHEK2—lymph node—duodenum cancer	0.00386	0.00391	CbGeAlD
Bosutinib—RPS6KB1—digestive system—duodenum cancer	0.00386	0.0039	CbGeAlD
Bosutinib—CSK—endocrine gland—duodenum cancer	0.00384	0.00389	CbGeAlD
Bosutinib—FGR—digestive system—duodenum cancer	0.00383	0.00388	CbGeAlD
Bosutinib—WEE1—lymph node—duodenum cancer	0.00383	0.00388	CbGeAlD
Bosutinib—DMPK—lymph node—duodenum cancer	0.00383	0.00388	CbGeAlD
Bosutinib—CSNK1A1—endocrine gland—duodenum cancer	0.00382	0.00387	CbGeAlD
Bosutinib—HCK—endocrine gland—duodenum cancer	0.00379	0.00384	CbGeAlD
Bosutinib—CLK1—endocrine gland—duodenum cancer	0.00379	0.00384	CbGeAlD
Bosutinib—YES1—pancreas—duodenum cancer	0.00377	0.00382	CbGeAlD
Bosutinib—TAOK3—pancreas—duodenum cancer	0.00373	0.00377	CbGeAlD
Bosutinib—BMP2K—endocrine gland—duodenum cancer	0.00372	0.00377	CbGeAlD
Bosutinib—CAMK2G—endocrine gland—duodenum cancer	0.00372	0.00377	CbGeAlD
Bosutinib—LRRK2—endocrine gland—duodenum cancer	0.00369	0.00374	CbGeAlD
Bosutinib—STK25—lymph node—duodenum cancer	0.00365	0.0037	CbGeAlD
Bosutinib—EPHB4—digestive system—duodenum cancer	0.00365	0.00369	CbGeAlD
Bosutinib—SRC—pancreas—duodenum cancer	0.00363	0.00368	CbGeAlD
Bosutinib—EPHA3—lymph node—duodenum cancer	0.00363	0.00367	CbGeAlD
Bosutinib—PTK2B—endocrine gland—duodenum cancer	0.0036	0.00364	CbGeAlD
Bosutinib—EPHA2—digestive system—duodenum cancer	0.00358	0.00362	CbGeAlD
Bosutinib—FYN—digestive system—duodenum cancer	0.00357	0.00362	CbGeAlD
Bosutinib—PLK2—lymph node—duodenum cancer	0.00355	0.0036	CbGeAlD
Bosutinib—CSNK1E—endocrine gland—duodenum cancer	0.00354	0.00358	CbGeAlD
Bosutinib—SIK3—lymph node—duodenum cancer	0.00353	0.00357	CbGeAlD
Bosutinib—SIK1—endocrine gland—duodenum cancer	0.00348	0.00353	CbGeAlD
Bosutinib—EPHA4—endocrine gland—duodenum cancer	0.00345	0.00349	CbGeAlD
Bosutinib—ERBB3—endocrine gland—duodenum cancer	0.00341	0.00346	CbGeAlD
Bosutinib—ULK3—endocrine gland—duodenum cancer	0.00341	0.00345	CbGeAlD
Bosutinib—MAP2K2—endocrine gland—duodenum cancer	0.00341	0.00345	CbGeAlD
Bosutinib—STK4—lymph node—duodenum cancer	0.0034	0.00344	CbGeAlD
Bosutinib—MAP3K2—endocrine gland—duodenum cancer	0.00338	0.00342	CbGeAlD
Bosutinib—CAMK1D—lymph node—duodenum cancer	0.00336	0.0034	CbGeAlD
Bosutinib—STK24—lymph node—duodenum cancer	0.00332	0.00336	CbGeAlD
Bosutinib—PTK2—endocrine gland—duodenum cancer	0.00331	0.00335	CbGeAlD
Bosutinib—TBK1—endocrine gland—duodenum cancer	0.00331	0.00335	CbGeAlD
Bosutinib—YES1—digestive system—duodenum cancer	0.00322	0.00326	CbGeAlD
Bosutinib—ALK—lymph node—duodenum cancer	0.00321	0.00325	CbGeAlD
Bosutinib—FER—lymph node—duodenum cancer	0.00321	0.00325	CbGeAlD
Bosutinib—STK10—digestive system—duodenum cancer	0.00319	0.00324	CbGeAlD
Bosutinib—RPS6KB1—endocrine gland—duodenum cancer	0.00319	0.00323	CbGeAlD
Bosutinib—TAOK3—digestive system—duodenum cancer	0.00318	0.00322	CbGeAlD
Bosutinib—FGR—endocrine gland—duodenum cancer	0.00317	0.00321	CbGeAlD
Bosutinib—AXL—endocrine gland—duodenum cancer	0.00315	0.00319	CbGeAlD
Bosutinib—MAP4K1—lymph node—duodenum cancer	0.00315	0.00319	CbGeAlD
Bosutinib—BTK—lymph node—duodenum cancer	0.00313	0.00317	CbGeAlD
Bosutinib—SRC—digestive system—duodenum cancer	0.0031	0.00314	CbGeAlD
Bosutinib—TNK2—lymph node—duodenum cancer	0.00308	0.00312	CbGeAlD
Bosutinib—MAP4K2—lymph node—duodenum cancer	0.00304	0.00308	CbGeAlD
Bosutinib—EPHB4—endocrine gland—duodenum cancer	0.00301	0.00305	CbGeAlD
Bosutinib—STK3—lymph node—duodenum cancer	0.003	0.00304	CbGeAlD
Bosutinib—EPHA2—endocrine gland—duodenum cancer	0.00296	0.00299	CbGeAlD
Bosutinib—FYN—endocrine gland—duodenum cancer	0.00295	0.00299	CbGeAlD
Bosutinib—PDGFRB—pancreas—duodenum cancer	0.00289	0.00293	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—duodenum cancer	0.00288	0.00292	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—duodenum cancer	0.00288	0.00292	CbGeAlD
Bosutinib—BMPR2—lymph node—duodenum cancer	0.00288	0.00291	CbGeAlD
Bosutinib—STK36—lymph node—duodenum cancer	0.00285	0.00289	CbGeAlD
Bosutinib—EPHB3—lymph node—duodenum cancer	0.00285	0.00289	CbGeAlD
Bosutinib—MERTK—lymph node—duodenum cancer	0.00282	0.00286	CbGeAlD
Bosutinib—CSF1R—digestive system—duodenum cancer	0.00278	0.00282	CbGeAlD
Bosutinib—MAP4K4—lymph node—duodenum cancer	0.00277	0.0028	CbGeAlD
Bosutinib—NUAK2—lymph node—duodenum cancer	0.00275	0.00278	CbGeAlD
Bosutinib—BCR—lymph node—duodenum cancer	0.00275	0.00278	CbGeAlD
Bosutinib—MAP3K12—lymph node—duodenum cancer	0.00273	0.00276	CbGeAlD
Bosutinib—STK35—lymph node—duodenum cancer	0.00267	0.00271	CbGeAlD
Bosutinib—MAP2K1—lymph node—duodenum cancer	0.00267	0.00271	CbGeAlD
Bosutinib—YES1—endocrine gland—duodenum cancer	0.00266	0.0027	CbGeAlD
Bosutinib—CSK—lymph node—duodenum cancer	0.00266	0.00269	CbGeAlD
Bosutinib—STK10—endocrine gland—duodenum cancer	0.00264	0.00267	CbGeAlD
Bosutinib—CSNK1A1—lymph node—duodenum cancer	0.00264	0.00267	CbGeAlD
Bosutinib—TAOK3—endocrine gland—duodenum cancer	0.00263	0.00266	CbGeAlD
Bosutinib—HCK—lymph node—duodenum cancer	0.00262	0.00266	CbGeAlD
Bosutinib—CLK1—lymph node—duodenum cancer	0.00262	0.00266	CbGeAlD
Bosutinib—ABL2—lymph node—duodenum cancer	0.00261	0.00264	CbGeAlD
Bosutinib—ABL1—pancreas—duodenum cancer	0.00258	0.00261	CbGeAlD
Bosutinib—CAMK2G—lymph node—duodenum cancer	0.00257	0.00261	CbGeAlD
Bosutinib—BMP2K—lymph node—duodenum cancer	0.00257	0.00261	CbGeAlD
Bosutinib—SRC—endocrine gland—duodenum cancer	0.00256	0.0026	CbGeAlD
Bosutinib—LRRK2—lymph node—duodenum cancer	0.00255	0.00258	CbGeAlD
Bosutinib—EGFR—lymph node—duodenum cancer	0.00254	0.00258	CbGeAlD
Bosutinib—PTK2B—lymph node—duodenum cancer	0.00249	0.00252	CbGeAlD
Bosutinib—PDGFRB—digestive system—duodenum cancer	0.00247	0.0025	CbGeAlD
Bosutinib—CSNK1E—lymph node—duodenum cancer	0.00245	0.00248	CbGeAlD
Bosutinib—SIK1—lymph node—duodenum cancer	0.00241	0.00244	CbGeAlD
Bosutinib—IRAK4—lymph node—duodenum cancer	0.00241	0.00244	CbGeAlD
Bosutinib—EPHA4—lymph node—duodenum cancer	0.00238	0.00241	CbGeAlD
Bosutinib—ERBB3—lymph node—duodenum cancer	0.00236	0.00239	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—duodenum cancer	0.00236	0.00239	CbGeAlD
Bosutinib—ULK3—lymph node—duodenum cancer	0.00235	0.00238	CbGeAlD
Bosutinib—MAP2K2—lymph node—duodenum cancer	0.00235	0.00238	CbGeAlD
Bosutinib—MAP3K2—lymph node—duodenum cancer	0.00234	0.00237	CbGeAlD
Bosutinib—MAP3K7—lymph node—duodenum cancer	0.00232	0.00235	CbGeAlD
Bosutinib—CSF1R—endocrine gland—duodenum cancer	0.0023	0.00233	CbGeAlD
Bosutinib—TBK1—lymph node—duodenum cancer	0.00229	0.00232	CbGeAlD
Bosutinib—PTK2—lymph node—duodenum cancer	0.00229	0.00232	CbGeAlD
Bosutinib—IRAK1—lymph node—duodenum cancer	0.00224	0.00227	CbGeAlD
Bosutinib—RPS6KB1—lymph node—duodenum cancer	0.0022	0.00223	CbGeAlD
Bosutinib—ABL1—digestive system—duodenum cancer	0.0022	0.00223	CbGeAlD
Bosutinib—LCK—lymph node—duodenum cancer	0.00219	0.00222	CbGeAlD
Bosutinib—FGR—lymph node—duodenum cancer	0.00219	0.00222	CbGeAlD
Bosutinib—AXL—lymph node—duodenum cancer	0.00218	0.00221	CbGeAlD
Bosutinib—SLK—lymph node—duodenum cancer	0.0021	0.00213	CbGeAlD
Bosutinib—EPHB4—lymph node—duodenum cancer	0.00208	0.00211	CbGeAlD
Bosutinib—EPHA2—lymph node—duodenum cancer	0.00204	0.00207	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—duodenum cancer	0.00204	0.00207	CbGeAlD
Bosutinib—FYN—lymph node—duodenum cancer	0.00204	0.00207	CbGeAlD
Bosutinib—MAP4K5—lymph node—duodenum cancer	0.00199	0.00202	CbGeAlD
Bosutinib—MAP3K3—lymph node—duodenum cancer	0.00199	0.00202	CbGeAlD
Bosutinib—YES1—lymph node—duodenum cancer	0.00184	0.00186	CbGeAlD
Bosutinib—STK10—lymph node—duodenum cancer	0.00182	0.00185	CbGeAlD
Bosutinib—ABL1—endocrine gland—duodenum cancer	0.00182	0.00184	CbGeAlD
Bosutinib—TAOK3—lymph node—duodenum cancer	0.00182	0.00184	CbGeAlD
Bosutinib—SRC—lymph node—duodenum cancer	0.00177	0.00179	CbGeAlD
Bosutinib—MAP2K5—lymph node—duodenum cancer	0.00163	0.00165	CbGeAlD
Bosutinib—CSF1R—lymph node—duodenum cancer	0.00159	0.00161	CbGeAlD
Bosutinib—PDGFRB—lymph node—duodenum cancer	0.00141	0.00143	CbGeAlD
Bosutinib—ABL1—lymph node—duodenum cancer	0.00126	0.00127	CbGeAlD
Bosutinib—CYP3A4—digestive system—duodenum cancer	0.000967	0.000979	CbGeAlD
Bosutinib—ABCB1—pancreas—duodenum cancer	0.000801	0.000812	CbGeAlD
Bosutinib—CYP3A4—endocrine gland—duodenum cancer	0.000799	0.000809	CbGeAlD
Bosutinib—ABCB1—digestive system—duodenum cancer	0.000684	0.000693	CbGeAlD
Bosutinib—WEE1—Cell Cycle—MEN1—duodenum cancer	0.000668	0.0532	CbGpPWpGaD
Bosutinib—PKMYT1—Cell Cycle—MEN1—duodenum cancer	0.000636	0.0506	CbGpPWpGaD
Bosutinib—ABCB1—endocrine gland—duodenum cancer	0.000565	0.000573	CbGeAlD
Bosutinib—CHEK2—Cell Cycle—MEN1—duodenum cancer	0.000486	0.0387	CbGpPWpGaD
Bosutinib—CDK2—Cell Cycle—MEN1—duodenum cancer	0.000438	0.0349	CbGpPWpGaD
Bosutinib—ABCB1—lymph node—duodenum cancer	0.000391	0.000396	CbGeAlD
Bosutinib—PRKCQ—G alpha (q) signalling events—GAST—duodenum cancer	0.000383	0.0305	CbGpPWpGaD
Bosutinib—PRKCQ—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000342	0.0273	CbGpPWpGaD
Bosutinib—CSNK1A1—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000281	0.0223	CbGpPWpGaD
Bosutinib—CSNK1A1—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000272	0.0216	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000252	0.0201	CbGpPWpGaD
Bosutinib—CSNK1E—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000227	0.018	CbGpPWpGaD
Bosutinib—CSNK1E—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000219	0.0175	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling by Wnt—MEN1—duodenum cancer	0.000208	0.0166	CbGpPWpGaD
Bosutinib—ABL1—Cell Cycle—MEN1—duodenum cancer	0.000207	0.0165	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000204	0.0162	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling by Wnt—MEN1—duodenum cancer	0.000168	0.0134	CbGpPWpGaD
Bosutinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000144	0.0115	CbGpPWpGaD
Bosutinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000135	0.0108	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—GAST—duodenum cancer	0.00013	0.0103	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—SCT—duodenum cancer	0.000123	0.0098	CbGpPWpGaD
Bosutinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000117	0.00934	CbGpPWpGaD
Bosutinib—PHKG1—Disease—MEN1—duodenum cancer	0.000116	0.00927	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—GAST—duodenum cancer	0.00011	0.00879	CbGpPWpGaD
Bosutinib—PRKCQ—GPCR downstream signaling—GAST—duodenum cancer	0.000109	0.00869	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—MEN1—duodenum cancer	0.000108	0.00857	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—SCT—duodenum cancer	0.000105	0.00833	CbGpPWpGaD
Bosutinib—PRKCQ—GPCR downstream signaling—SCT—duodenum cancer	0.000103	0.00824	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling by Wnt—MEN1—duodenum cancer	0.0001	0.00799	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—GAST—duodenum cancer	9.91e-05	0.00789	CbGpPWpGaD
Bosutinib—BCR—Disease—MEN1—duodenum cancer	9.49e-05	0.00756	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—SCT—duodenum cancer	9.39e-05	0.00748	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—GAST—duodenum cancer	9.25e-05	0.00737	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—MEN1—duodenum cancer	9.15e-05	0.00729	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—SST—duodenum cancer	8.9e-05	0.00709	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—GAST—duodenum cancer	8.77e-05	0.00698	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—SCT—duodenum cancer	8.77e-05	0.00698	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—GAST—duodenum cancer	8.37e-05	0.00666	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—SCT—duodenum cancer	8.32e-05	0.00662	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—GAST—duodenum cancer	8.02e-05	0.00639	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—SCT—duodenum cancer	7.93e-05	0.00632	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—MEN1—duodenum cancer	7.67e-05	0.00611	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—SCT—duodenum cancer	7.61e-05	0.00606	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—SST—duodenum cancer	7.57e-05	0.00603	CbGpPWpGaD
Bosutinib—PRKCQ—GPCR downstream signaling—SST—duodenum cancer	7.48e-05	0.00595	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—MEN1—duodenum cancer	7.27e-05	0.00579	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—GAST—duodenum cancer	7.23e-05	0.00576	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—GAST—duodenum cancer	7.01e-05	0.00558	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—MEN1—duodenum cancer	6.93e-05	0.00552	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—MEN1—duodenum cancer	6.93e-05	0.00551	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—MEN1—duodenum cancer	6.93e-05	0.00551	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—SCT—duodenum cancer	6.86e-05	0.00546	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling by GPCR—SST—duodenum cancer	6.79e-05	0.00541	CbGpPWpGaD
Bosutinib—CSK—Disease—MEN1—duodenum cancer	6.69e-05	0.00533	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—MEN1—duodenum cancer	6.65e-05	0.00529	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SCT—duodenum cancer	6.65e-05	0.00529	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—GAST—duodenum cancer	6.57e-05	0.00523	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—SST—duodenum cancer	6.34e-05	0.00505	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—SCT—duodenum cancer	6.23e-05	0.00496	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—SST—duodenum cancer	6.01e-05	0.00479	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—GAST—duodenum cancer	5.96e-05	0.00475	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—GAST—duodenum cancer	5.85e-05	0.00466	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—GAST—duodenum cancer	5.85e-05	0.00466	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—MEN1—duodenum cancer	5.81e-05	0.00463	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—SST—duodenum cancer	5.74e-05	0.00457	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SCT—duodenum cancer	5.65e-05	0.0045	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—GAST—duodenum cancer	5.65e-05	0.0045	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—MEN1—duodenum cancer	5.59e-05	0.00446	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SCT—duodenum cancer	5.55e-05	0.00442	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SCT—duodenum cancer	5.55e-05	0.00442	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—SST—duodenum cancer	5.5e-05	0.00438	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SCT—duodenum cancer	5.36e-05	0.00427	CbGpPWpGaD
Bosutinib—HCK—Disease—MEN1—duodenum cancer	5.13e-05	0.00409	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—SST—duodenum cancer	4.96e-05	0.00395	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—MEN1—duodenum cancer	4.94e-05	0.00393	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—MEN1—duodenum cancer	4.85e-05	0.00386	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—MEN1—duodenum cancer	4.85e-05	0.00386	CbGpPWpGaD
Bosutinib—ERBB4—Disease—MEN1—duodenum cancer	4.84e-05	0.00385	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SST—duodenum cancer	4.81e-05	0.00383	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—GAST—duodenum cancer	4.73e-05	0.00377	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—MEN1—duodenum cancer	4.68e-05	0.00373	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—SST—duodenum cancer	4.5e-05	0.00358	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SCT—duodenum cancer	4.48e-05	0.00357	CbGpPWpGaD
Bosutinib—ERBB3—Disease—MEN1—duodenum cancer	4.26e-05	0.00339	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—GAST—duodenum cancer	4.18e-05	0.00333	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—GAST—duodenum cancer	4.09e-05	0.00325	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SST—duodenum cancer	4.09e-05	0.00325	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—GAST—duodenum cancer	4.03e-05	0.00321	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SST—duodenum cancer	4.01e-05	0.00319	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SST—duodenum cancer	4.01e-05	0.00319	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—SCT—duodenum cancer	3.96e-05	0.00315	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MEN1—duodenum cancer	3.92e-05	0.00312	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—GAST—duodenum cancer	3.91e-05	0.00311	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—GAST—duodenum cancer	3.88e-05	0.00309	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SCT—duodenum cancer	3.87e-05	0.00308	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SST—duodenum cancer	3.87e-05	0.00308	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SCT—duodenum cancer	3.82e-05	0.00304	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—GAST—duodenum cancer	3.74e-05	0.00298	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—GAST—duodenum cancer	3.74e-05	0.00298	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—SCT—duodenum cancer	3.71e-05	0.00295	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SCT—duodenum cancer	3.68e-05	0.00293	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—GAST—duodenum cancer	3.6e-05	0.00287	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SCT—duodenum cancer	3.54e-05	0.00282	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SCT—duodenum cancer	3.54e-05	0.00282	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SCT—duodenum cancer	3.42e-05	0.00272	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—GAST—duodenum cancer	3.4e-05	0.0027	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MEN1—duodenum cancer	3.39e-05	0.0027	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MEN1—duodenum cancer	3.34e-05	0.00266	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SST—duodenum cancer	3.24e-05	0.00258	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—SCT—duodenum cancer	3.22e-05	0.00256	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MEN1—duodenum cancer	3.21e-05	0.00256	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—GAST—duodenum cancer	3.21e-05	0.00255	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—GAST—duodenum cancer	3.16e-05	0.00252	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MEN1—duodenum cancer	3.1e-05	0.00247	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MEN1—duodenum cancer	3.1e-05	0.00247	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SCT—duodenum cancer	3.04e-05	0.00242	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—GAST—duodenum cancer	3e-05	0.00239	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SCT—duodenum cancer	3e-05	0.00239	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MEN1—duodenum cancer	2.99e-05	0.00238	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—MEN1—duodenum cancer	2.92e-05	0.00233	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—SST—duodenum cancer	2.86e-05	0.00228	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—MEN1—duodenum cancer	2.85e-05	0.00227	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SCT—duodenum cancer	2.84e-05	0.00226	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—GAST—duodenum cancer	2.82e-05	0.00225	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SST—duodenum cancer	2.8e-05	0.00223	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SST—duodenum cancer	2.76e-05	0.0022	CbGpPWpGaD
Bosutinib—FYN—Disease—MEN1—duodenum cancer	2.75e-05	0.00219	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—MEN1—duodenum cancer	2.73e-05	0.00218	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—SST—duodenum cancer	2.68e-05	0.00213	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SCT—duodenum cancer	2.68e-05	0.00213	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SST—duodenum cancer	2.66e-05	0.00212	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MEN1—duodenum cancer	2.66e-05	0.00212	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MEN1—duodenum cancer	2.62e-05	0.00209	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SST—duodenum cancer	2.56e-05	0.00204	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SST—duodenum cancer	2.56e-05	0.00204	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MEN1—duodenum cancer	2.49e-05	0.00198	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SST—duodenum cancer	2.47e-05	0.00197	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—GAST—duodenum cancer	2.47e-05	0.00197	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—GAST—duodenum cancer	2.41e-05	0.00192	CbGpPWpGaD
Bosutinib—EGFR—Disease—MEN1—duodenum cancer	2.37e-05	0.00189	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—GAST—duodenum cancer	2.36e-05	0.00188	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MEN1—duodenum cancer	2.34e-05	0.00186	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SCT—duodenum cancer	2.34e-05	0.00186	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—SST—duodenum cancer	2.33e-05	0.00185	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—GAST—duodenum cancer	2.32e-05	0.00185	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—GAST—duodenum cancer	2.31e-05	0.00184	CbGpPWpGaD
Bosutinib—LCK—Disease—MEN1—duodenum cancer	2.29e-05	0.00182	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SCT—duodenum cancer	2.28e-05	0.00182	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SCT—duodenum cancer	2.24e-05	0.00178	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SCT—duodenum cancer	2.2e-05	0.00175	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SST—duodenum cancer	2.2e-05	0.00175	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SCT—duodenum cancer	2.19e-05	0.00174	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SST—duodenum cancer	2.17e-05	0.00173	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SST—duodenum cancer	2.06e-05	0.00164	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MEN1—duodenum cancer	2.05e-05	0.00163	CbGpPWpGaD
Bosutinib—SRC—Disease—MEN1—duodenum cancer	2.02e-05	0.00161	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GAST—duodenum cancer	2.01e-05	0.0016	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MEN1—duodenum cancer	2e-05	0.00159	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MEN1—duodenum cancer	1.95e-05	0.00156	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SST—duodenum cancer	1.94e-05	0.00154	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GAST—duodenum cancer	1.93e-05	0.00154	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MEN1—duodenum cancer	1.92e-05	0.00153	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MEN1—duodenum cancer	1.91e-05	0.00152	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SCT—duodenum cancer	1.9e-05	0.00151	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SCT—duodenum cancer	1.83e-05	0.00146	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GAST—duodenum cancer	1.71e-05	0.00136	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SST—duodenum cancer	1.69e-05	0.00135	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MEN1—duodenum cancer	1.66e-05	0.00132	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SST—duodenum cancer	1.65e-05	0.00131	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SCT—duodenum cancer	1.62e-05	0.00129	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SST—duodenum cancer	1.62e-05	0.00129	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MEN1—duodenum cancer	1.6e-05	0.00128	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SST—duodenum cancer	1.59e-05	0.00127	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SST—duodenum cancer	1.58e-05	0.00126	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MEN1—duodenum cancer	1.42e-05	0.00113	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SST—duodenum cancer	1.37e-05	0.00109	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SST—duodenum cancer	1.32e-05	0.00105	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SST—duodenum cancer	1.17e-05	0.000934	CbGpPWpGaD
